MoxDuo IR morphine/oxycodone regulatory update

FDA accepted for review an NDA submitted by QRxPharma for MoxDuo IR morphine/oxycodone to treat moderate to severe acute pain. The PDUFA date is June 25, 2012. The company submitted the NDA under sect...